• AAPL 173.18
  • TSLA 180.1
  • AMZN 184.72
  • MSFT 397.84
  • INTC 30.515
  • EURUSD 1.0739
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. ST /
  3. CLBIO.ST

Corline Biomedical AB (CLBIO ST) stock market data APIs

kr10.95 0.4(3.8%) as of May 2, 2024

Corline Biomedical AB Financial Data Overview

10.97
10.95
-
10.6
10.72
10-19.85
227 M
21 491 K
35 519 K
-0.0279
0.475
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CLBIO',
Type: 'Common Stock',
Name: 'Corline Biomedical AB',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
OpenFigi: NULL,
ISIN: 'SE0006887451',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Corline Biomedical AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 35 519 K
  • EBITDA -1 691 000
  • Earnings Per Share -0.04
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Corline Biomedical AB Earnings via APIs

  • Latest Release 2024-02-14
  • EPS/Forecast NaN

Get Corline Biomedical AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Corline Biomedical AB latest news via APIs

Corline Biomedical AB publicerar delårsrapport för det tredje kvartalet 2023

Corline Biomedical AB (”Corline”) publicerar härmed delårsrapporten för perioden januari till september 2023. Nedan följer en kort sammanfattning av delårsrapporten. Fullständig rapport finn...
  • COMPANY ANNOUNCEMENT
  • CORLINE
  • CORLINE BIOMEDICAL AB
  • EUROPEAN REGULATORY NEWS
  • EX VIVO TREATMENT
  • INTERIM INFORMATION
  • KIDNEY TRANSPLANTATION
  • MEDICAL DEVICE COATING
  • PHARMA DEVELOPMENT
  • RENAPARIN
  • STOCKHOLM STOCK EXCHANGE:CLBIO

12-månadersuppföljning stödjer säkerhet och indikerar positiv behandlingseffekt av Renaparin®

Corline Biomedical AB (”Corline”) meddelar härmed resultat efter uppföljning i 12 månader av behandlade patienter i RENAPAIR 01 samt vid jämförelse med transplanterade parnjurar. I septembe...
  • COMPANY ANNOUNCEMENT
  • CORLINE
  • CORLINE BIOMEDICAL AB
  • EUROPEAN REGULATORY NEWS
  • EX VIVO TREATMENT
  • KIDNEY TRANSPLANTATION
  • PHARMA DEVELOPMENT
  • RENAPARIN
  • STOCKHOLM STOCK EXCHANGE:CLBIO
Do you have any questions?
support@eodhistoricaldata.com